Clinical Trials for Intercept Pharmaceuticals

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Intercept Pharmaceuticals

Clinical Trials (5)

NCT06121375
Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy
PHASE2/PHASE3Active, not recruiting
144 participants
Started: Sep 2, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor24 locations
NCT06488911
To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate
PHASE3Active, not recruiting
133 participants
Started: Jul 1, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor51 locations
NCT05639543
FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study
PHASE2Recruiting
80 participants
Started: Dec 15, 2022 · Completed: Apr 1, 2027
1 condition1 sponsor31 locations
NCT04594694
Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC
PHASE2Active, not recruiting
72 participants
Started: Oct 2, 2019 · Completed: Oct 31, 2025
1 condition1 sponsor33 locations
NCT05479721
LITMUS Imaging Study
N/AActive, not recruiting
450 participants
Started: Sep 4, 2019 · Completed: Oct 31, 2025
5 conditions24 sponsors18 locations